MedPath

A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face

Phase 1
Completed
Conditions
Enlarged Pores
Sebum Production
Registration Number
NCT05784363
Lead Sponsor
Merz North America, Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Cheek pore size assessed as large by the investigator<br><br> - Oily skin on the forehead<br><br>Exclusion Criteria:<br><br> - Treatment with Botulinum toxin (BoNT) of any serotype in the face within the last 12<br> months<br><br> - Facial cosmetic procedure (e.g., chemical peel, photo rejuvenation, mesotherapy,<br> photodynamic therapy, laser treatment, ultrasound treatment, tattooing of eyebrows)<br> within the last 12 months<br><br> - Treatment with any dermal filler in the face within the last 12 months<br><br> - Any previous insertion of permanent material in the face, including permanent dermal<br> fillers (e.g., silicone, polymethyl methacrylate)<br><br> - Any medical condition that may put the subject at increased risk with exposure to<br> botulinum toxin of any serotype

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from Baseline to Week 4 in Pore Volume in the Cheek Area;Change from Baseline to Week 4 in Sebum Level in the Forehead Area
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath